Cargando…
Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients
Genetic testing using reverse transcriptase real-time polymerase chain reaction (rRT-PCR) is the mainstay of diagnosis of COVID-19. However, it has not been fully investigated whether infectious viruses are contained in SARS-CoV-2 genome-positive specimens examined using the rRT-PCR test. In this st...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578003/ https://www.ncbi.nlm.nih.gov/pubmed/34774431 http://dx.doi.org/10.1016/j.jiac.2021.10.028 |
_version_ | 1784596181948563456 |
---|---|
author | Igarashi, Emiko Tani, Hideki Tamura, Kosuke Itamochi, Masae Shimada, Takahisa Saga, Yumiko Inasaki, Noriko Hasegawa, Sumiyo Yazawa, Shunsuke Sasajima, Hitoshi Kaya, Hiroyasu Nomura, Satoshi Itoh, Hiroyuki Takeda, Shin-ichi Yamamoto, Yoshihiro Yamashiro, Seiji Ichikawa, Tomomi Horie, Yukio Hirota, Kojiro Hirano, Norikazu Kawashiri, Chikako Oishi, Kazunori |
author_facet | Igarashi, Emiko Tani, Hideki Tamura, Kosuke Itamochi, Masae Shimada, Takahisa Saga, Yumiko Inasaki, Noriko Hasegawa, Sumiyo Yazawa, Shunsuke Sasajima, Hitoshi Kaya, Hiroyasu Nomura, Satoshi Itoh, Hiroyuki Takeda, Shin-ichi Yamamoto, Yoshihiro Yamashiro, Seiji Ichikawa, Tomomi Horie, Yukio Hirota, Kojiro Hirano, Norikazu Kawashiri, Chikako Oishi, Kazunori |
author_sort | Igarashi, Emiko |
collection | PubMed |
description | Genetic testing using reverse transcriptase real-time polymerase chain reaction (rRT-PCR) is the mainstay of diagnosis of COVID-19. However, it has not been fully investigated whether infectious viruses are contained in SARS-CoV-2 genome-positive specimens examined using the rRT-PCR test. In this study, we examined the correlation between the threshold Cycle (Ct) value obtained from the rRT-PCR test and virus isolation in cultured cells, using 533 consecutive clinical specimens of COVID-19 patients. The virus was isolated from specimens with a Ct value of less than 30 cycles, and the lower the Ct value, the more efficient the isolation rate. A cytopathic effect due to herpes simplex virus type 1 contamination was observed in one sample with a Ct value of 35 cycles. In a comparison of VeroE6/TMPRSS2 cells and VeroE6 cells used for virus isolation, VeroE6/TMPRSS2 cells isolated the virus 1.7 times more efficiently than VeroE6 cells. There was no significant difference between the two cells in the mean Ct value of the detectable sample. In conclusion, Lower Ct values in the PCR test were associated with higher virus isolation rates, and VeroE6/TMPRSS2 cells were able to isolate viruses more efficiently than VeroE6 cells. |
format | Online Article Text |
id | pubmed-8578003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85780032021-11-10 Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients Igarashi, Emiko Tani, Hideki Tamura, Kosuke Itamochi, Masae Shimada, Takahisa Saga, Yumiko Inasaki, Noriko Hasegawa, Sumiyo Yazawa, Shunsuke Sasajima, Hitoshi Kaya, Hiroyasu Nomura, Satoshi Itoh, Hiroyuki Takeda, Shin-ichi Yamamoto, Yoshihiro Yamashiro, Seiji Ichikawa, Tomomi Horie, Yukio Hirota, Kojiro Hirano, Norikazu Kawashiri, Chikako Oishi, Kazunori J Infect Chemother Note Genetic testing using reverse transcriptase real-time polymerase chain reaction (rRT-PCR) is the mainstay of diagnosis of COVID-19. However, it has not been fully investigated whether infectious viruses are contained in SARS-CoV-2 genome-positive specimens examined using the rRT-PCR test. In this study, we examined the correlation between the threshold Cycle (Ct) value obtained from the rRT-PCR test and virus isolation in cultured cells, using 533 consecutive clinical specimens of COVID-19 patients. The virus was isolated from specimens with a Ct value of less than 30 cycles, and the lower the Ct value, the more efficient the isolation rate. A cytopathic effect due to herpes simplex virus type 1 contamination was observed in one sample with a Ct value of 35 cycles. In a comparison of VeroE6/TMPRSS2 cells and VeroE6 cells used for virus isolation, VeroE6/TMPRSS2 cells isolated the virus 1.7 times more efficiently than VeroE6 cells. There was no significant difference between the two cells in the mean Ct value of the detectable sample. In conclusion, Lower Ct values in the PCR test were associated with higher virus isolation rates, and VeroE6/TMPRSS2 cells were able to isolate viruses more efficiently than VeroE6 cells. Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022-02 2021-11-10 /pmc/articles/PMC8578003/ /pubmed/34774431 http://dx.doi.org/10.1016/j.jiac.2021.10.028 Text en © 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Note Igarashi, Emiko Tani, Hideki Tamura, Kosuke Itamochi, Masae Shimada, Takahisa Saga, Yumiko Inasaki, Noriko Hasegawa, Sumiyo Yazawa, Shunsuke Sasajima, Hitoshi Kaya, Hiroyasu Nomura, Satoshi Itoh, Hiroyuki Takeda, Shin-ichi Yamamoto, Yoshihiro Yamashiro, Seiji Ichikawa, Tomomi Horie, Yukio Hirota, Kojiro Hirano, Norikazu Kawashiri, Chikako Oishi, Kazunori Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title | Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title_full | Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title_fullStr | Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title_full_unstemmed | Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title_short | Viral isolation analysis of SARS-CoV-2 from clinical specimens of COVID-19 patients |
title_sort | viral isolation analysis of sars-cov-2 from clinical specimens of covid-19 patients |
topic | Note |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8578003/ https://www.ncbi.nlm.nih.gov/pubmed/34774431 http://dx.doi.org/10.1016/j.jiac.2021.10.028 |
work_keys_str_mv | AT igarashiemiko viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT tanihideki viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT tamurakosuke viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT itamochimasae viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT shimadatakahisa viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT sagayumiko viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT inasakinoriko viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT hasegawasumiyo viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT yazawashunsuke viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT sasajimahitoshi viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT kayahiroyasu viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT nomurasatoshi viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT itohhiroyuki viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT takedashinichi viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT yamamotoyoshihiro viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT yamashiroseiji viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT ichikawatomomi viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT horieyukio viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT hirotakojiro viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT hiranonorikazu viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT kawashirichikako viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients AT oishikazunori viralisolationanalysisofsarscov2fromclinicalspecimensofcovid19patients |